| Asthma: Mechanisms of Disease Persistence and Progression L Cohn, JA Elias, GL Chupp Annu. Rev. Immunol. 22 (1), 789-815, 2004 | 1303 | 2004 |
| Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis TS Adams, JC Schupp, S Poli, EA Ayaub, N Neumark, F Ahangari, ... Science advances 6 (28), eaba1983, 2020 | 1061 | 2020 |
| Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury CG Lee, CA Da Silva, CS Dela Cruz, F Ahangari, B Ma, MJ Kang, CH He, ... Annual review of physiology 73 (1), 479-501, 2011 | 961 | 2011 |
| Manganese is essential for neuronal health KJ Horning, SW Caito, KG Tipps, AB Bowman, M Aschner Annual review of nutrition 35 (1), 71-108, 2015 | 579 | 2015 |
| Chitinase 3-like 1 regulates cellular and tissue responses via IL-13 receptor α2 CH He, CG Lee, CSD Cruz, CM Lee, Y Zhou, F Ahangari, B Ma, ... Cell reports 4 (4), 830-841, 2013 | 328 | 2013 |
| Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer K Spring, F Ahangari, SP Scott, P Waring, DM Purdie, PC Chen, ... Nature genetics 32 (1), 185-190, 2002 | 323 | 2002 |
| Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function G Yu, A Tzouvelekis, R Wang, JD Herazo-Maya, GH Ibarra, A Srivastava, ... Nature medicine 24 (1), 39-49, 2018 | 310 | 2018 |
| Integrated single-cell atlas of endothelial cells of the human lung JC Schupp, TS Adams, C Cosme Jr, MSB Raredon, Y Yuan, N Omote, ... Circulation 144 (4), 286-302, 2021 | 299 | 2021 |
| LungMAP: the molecular atlas of lung development program ME Ardini-Poleske, RF Clark, C Ansong, JP Carson, RA Corley, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 313 (5 …, 2017 | 197 | 2017 |
| Transcriptional regulatory model of fibrosis progression in the human lung JE McDonough, F Ahangari, Q Li, S Jain, SE Verleden, J Herazo-Maya, ... JCI insight 4 (22), 2019 | 153 | 2019 |
| Reconstructed single-cell fate trajectories define lineage plasticity windows during differentiation of human PSC-derived distal lung progenitors K Hurley, J Ding, C Villacorta-Martin, MJ Herriges, A Jacob, M Vedaie, ... Cell stem cell 26 (4), 593-608. e8, 2020 | 130 | 2020 |
| Chitinase 1 is a biomarker for and therapeutic target in scleroderma-associated interstitial lung disease that augments TGF-β1 signaling CG Lee, EL Herzog, F Ahangari, Y Zhou, M Gulati, CM Lee, X Peng, ... The journal of immunology 189 (5), 2635-2644, 2012 | 118 | 2012 |
| Studies of vascular endothelial growth factor in asthma and chronic obstructive pulmonary disease CG Lee, B Ma, S Takyar, F Ahangari, C DelaCruz, CH He, JA Elias Proceedings of the American Thoracic Society 8 (6), 512-515, 2011 | 112 | 2011 |
| Chitinase 3–like-1 regulates both visceral fat accumulation and asthma-like Th2 inflammation F Ahangari, A Sood, B Ma, S Takyar, M Schuyler, C Qualls, CS Dela Cruz, ... American Journal of Respiratory and Critical Care Medicine 191 (7), 746-757, 2015 | 99 | 2015 |
| VEGF controls lung Th2 inflammation via the miR-1–Mpl (myeloproliferative leukemia virus oncogene)–P-selectin axis S Takyar, H Vasavada, J Zhang, F Ahangari, N Niu, Q Liu, CG Lee, ... Journal of Experimental Medicine 210 (10), 1993-2010, 2013 | 82 | 2013 |
| Atm Knock-in Mice Harboring an In-frame Deletion Corresponding to the Human ATM 7636del9 Common Mutation Exhibit a Variant Phenotype K Spring, S Cross, C Li, D Watters, L Ben-Senior, P Waring, F Ahangari, ... Cancer research 61 (11), 4561-4568, 2001 | 78 | 2001 |
| Single-cell transcriptional archetypes of airway inflammation in cystic fibrosis JC Schupp, S Khanal, JL Gomez, M Sauler, TS Adams, GL Chupp, X Yan, ... American journal of respiratory and critical care medicine 202 (10), 1419-1429, 2020 | 74 | 2020 |
| A lung targeted miR-29 mimic as a therapy for pulmonary fibrosis M Chioccioli, S Roy, R Newell, L Pestano, B Dickinson, K Rigby, ... EBioMedicine 85, 2022 | 68 | 2022 |
| SH2 domain–containing phosphatase-2 is a novel antifibrotic regulator in pulmonary fibrosis A Tzouvelekis, G Yu, CL Lino Cardenas, JD Herazo-Maya, R Wang, ... American journal of respiratory and critical care medicine 195 (4), 500-514, 2017 | 60 | 2017 |
| Saracatinib, a selective src kinase inhibitor, blocks fibrotic responses in preclinical models of pulmonary fibrosis F Ahangari, C Becker, DG Foster, M Chioccioli, M Nelson, K Beke, ... American Journal of Respiratory and Critical Care Medicine 206 (12), 1463-1479, 2022 | 59 | 2022 |
Naftali KaminskiYale School of MedicineEmail verificata su yale.edu